Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms

Copy number variation and high expression of DNA topoisomerase II alpha predict worse prognosis of cancer: a meta-analysis

(2018) Ling Ren et al.   Journal of Cancer

Overexpression of G2 and S phase-expressed-1 contributes to cell proliferation, migration, and invasion via regulating p53/FoxM1/CCNB1 pathway and predicts poor prognosis in bladder cancer

(2018) Anwei Liu et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

(2017) J. Alfred Witjes et al.   EUROPEAN UROLOGY

Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma

(2017) Shuxiong Zeng et al.   Scientific Reports

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer

(2015) Jason S. Kirk et al.   Oncotarget

PIAS3 expression in squamous cell lung cancer is low and predicts overall survival

(2015) Rime Abbas et al.   Cancer Medicine

Comprehensive molecular characterization of urothelial bladder carcinoma

(2014)   NATURE

TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma

(2013) Meenu Jain et al.   ENDOCRINE-RELATED CANCER

Higher Expression of Topoisomerase II Alpha Is an Independent Marker of Increased Risk of Cancer-specific Death in Patients with Clear Cell Renal Cell Carcinoma

(2013) Alexander S. Parker et al.   EUROPEAN UROLOGY

Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells

(2013) S Belluti et al.   Cell Death & Disease

Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line

(2012) Shatha AbuHammad et al.   GENOMICS

Expression Profiling of Liposarcoma Yields a Multigene Predictor of Patient Outcome and Identifies Genes That Contribute to Liposarcomagenesis

(2011) R. M. Gobble et al.   CANCER RESEARCH

Differential expression in RNA-seq: A matter of depth

(2011) S. Tarazona et al.   GENOME RESEARCH

ERBB2 and TOP2A in Breast Cancer: A Comprehensive Analysis of Gene Amplification, RNA Levels, and Protein Expression and Their Influence on Prognosis and Prediction

(2010) J. C. Brase et al.   CLINICAL CANCER RESEARCH

Clinical Implications and Prognostic Values of Topoisomerase-II Alpha Expression in Primary Non–muscle-invasive Bladder Cancer

(2009) Eun-Jung Kim et al.   UROLOGY